Solid Biosciences Inc.
SLDB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $39 | $32 | $31 | $31 |
| G&A Expenses | $9 | $9 | $9 | $9 |
| SG&A Expenses | $9 | $9 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | $0 |
| Operating Expenses | $48 | $41 | $40 | $40 |
| Operating Income | -$48 | -$42 | -$40 | -$40 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | $2 | $1 | -$3 |
| Pre-Tax Income | -$46 | -$39 | -$39 | -$43 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$46 | -$39 | -$39 | -$43 |
| % Margin | – | – | – | – |
| EPS | -0.48 | -0.42 | -0.59 | -0.8 |
| % Growth | -14.3% | 28.8% | 26.3% | – |
| EPS Diluted | -0.48 | -0.42 | -0.59 | -0.8 |
| Weighted Avg Shares Out | 94 | 94 | 66 | 54 |
| Weighted Avg Shares Out Dil | 94 | 94 | 66 | 54 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$45 | -$39 | -$39 | -$42 |
| % Margin | – | – | – | – |